Editas Medicine raises $94.4 million in year’s first IPO

Prominent health policy researcher plagiarized colleagues’ work, Dartmouth investigation finds

A startup promised to make health care ‘refreshingly simple.’ Building the business has been anything but

New on the streets: Gabapentin, a drug for nerve pain, and a new target of misuse